Back to AG ADAGE CAPITAL PARTNERS GP, L.L.C.

XENEXENE
Showing 8 of 31 quarters

Position history for AGADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in XENON PHARMACEUTICALS INC

ADAGE CAPITAL PARTNERS GP, L.L.C. holds 300,000 shares of XENE (XENON PHARMACEUTICALS INC), worth $18.1M as of 2026-Q2. The position was decreased (-36.2% shares). XENE represents 0.0% of ADAGE CAPITAL PARTNERS GP, L.L.C.'s portfolio.

Current Value

$18.1M

Current Shares

300,000

Total Value Change

-$63.9M

Total Shares Change

-1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
300,000
-36.2%
$18.1M0.0%$60.36
0
2026-Q1
Decreased
470,000
-31.4%
$27.3M0.0%$43.79
0
2025-Q4
Decreased
685,100
-18.0%
$30.7M0.0%$44.12
0
2025-Q3
Decreased
835,100
-35.3%
$33.5M0.1%$39.06
0
2025-Q2
Decreased
1.3M
-32.6%
$40.4M0.1%$32.40
0
2025-Q1
Increased
1.9M
+2.8%
$64.2M0.1%$34.26
36
2024-Q4
Decreased
1.9M
-10.6%
$73M0.1%$38.53
0
2024-Q3
Increased
2.1M
+13.3%
$82M0.1%$38.65
40

Other major holders of XENE: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used